Yu Wande

5PUBLICATIONS
12CO-AUTHORS
Respiratory diseasesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 03, 2026
Diffusing Capacity of the Lung for Carbon Monoxide and the Risk of All-Cause Mortality in Patients With Pulmonary Hypertension Caused by Fibrosing Mediastinitis: A Multicenter Cohort Study.

|Nov 18, 2025
Substance P Promotes Pulmonary Hypertension by Inducing Fibulin-2 Methylation to Regulate β-Catenin.

Wang Yi, Zhu Minghui, Zhu Le

|Aug 01, 2022
Apolipoprotein A1 is associated with pulmonary vascular resistance and adverse clinical outcomes in patients with pulmonary hypertension secondary to heart failure.

Wande Yu, Xie Dujiang, Wang Yi

|Aug 23, 2018
Norepinephrine stimulation downregulates the β2 -adrenergic receptor-nitric oxide pathway in human pulmonary artery endothelial cells.

Wande Yu, Yue Gu, PeiP Chen

|Aug 06, 2018
Berberine attenuates pulmonary arterial hypertension via protein phosphatase 2A signaling pathway both in vivo and in vitro.

Jie Luo, Yue Gu, Pengfei Liu

Pageof 1

Frequent Collaborators

2 joint publications

Jie Luo

2 joint publications

Yuelin Chao

1 joint publications

Peng Ye

1 joint publications

Hongfeng Yang